This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Elise Melon
Global Legal Affairs, Head of Strategy, Operations & Policy at UCB


Elise Melon joined UCB in 2017, a global biopharmaceutical company focusing on creating valuable solutions for people living with neurological and autoimmune conditions, as Head of IP Policy and Operations. As such, she managed a team of IP paralegals and several IP operations and policy specialists.

In 2022, she took on a broader role as Head of Strategy, Operations and Policy for UCB Legal Department, coordinating strategic planning, transversal operations and policy activities across the department.

Before joining UCB, Elise Melon worked for 5 years at the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents the research-based and innovative pharmaceutical industry in the EU. As Director for Intellectual Property Policy, she coordinated the development of EFPIA’s IP and innovation policy within and outside the EU.

Today, she is Vice-Chair of EFPIA’s IP Expert Group and contributes to many other working groups in various national and international trade associations.

She holds a Bachelor's degree in Political sciences and European Studies from Sciences Po Paris and two Masters of Law in Intellectual Property Law from Sciences Po Paris and in European Law and Economic Analysis from the College of Europe (Bruges).

Agenda Sessions

  • KEYNOTE PANEL Exploring Progress on Proposals in the EU Pharmaceutical Legislation Revision